Valeant completes $11.11 billion buyout of Salix

April 1, 2015 5:16 PM

57 0

Valeant Pharmaceuticals International Inc. completed its $11.11 billion buyout of Salix Pharmaceuticals Ltd. on Wednesday.

In March, Valeant raised its offer for Salix to $173 per share from $158 per share, forcing rival bidder Endo International out of what had become a bidding war.

Also read: Cameron Wake's new two-year deal worth $19 million, per source

Read more

To category page

Loading...